ARTICLE | Clinical News
Topiglan: Phase I; Phase II
April 14, 2003 7:00 AM UTC
MCHM said the FDA released a clinical hold on compounds using the company's SEPA absorption enhancer technology, including Topiglan. As a result, MCHM will begin Phase II testing of Topiglan this year...